Company / CapEx per Share
Moleculin Biotech, Inc. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.10
FY2025
5-year range
$0.03 / $0.10
FY2021-FY2025
Trend
+72.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share has increased for 4 consecutive years, from $0.01 in FY2020 to $0.10 in FY2025.
Based on SEC 10-K filings.
0.10 in FY2025 with a 5-year CAGR of +69.8%.
Improved from $0.04 to $0.10 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +69.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, capex per share increased 72.8% year-over-year.
- Lowest capex per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.10 | +72.8% |
| FY2024 | $0.06 | +58.6% |
| FY2023 | $0.04 | - |
| FY2022 | - | - |
| FY2021 | $0.03 | +377.7% |
| FY2020 | $0.01 | -53.3% |
| FY2019 | $0.01 | +1020.8% |
| FY2018 | $0.00 | -24.5% |
| FY2017 | $0.00 | - |
| FY2016 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026